CTN :44915793
06 May, 2026
NA
Tender For bid to ras supply of dicyclomine hcl 10 mg , inj esmolol 100 mg per 10 ml , inj magnessium sulphate 50 percent w_v , acetazolamide 0 point 25g tab , dexamethasone 4 mg , tab etoricoxib 90 mg , febuxostat 40 mg tab , levetiracetam 500 mg tab , tab domperidone 10mg plus pantoprazole 40mg , chlorzoxazone 500 mg plus diclofenac sodium 50 mg plus paracetamol 325 mg tab , tamsulosin hcl 0 point 4mg cap , telmisartan 40 mg plus hydrochlorothiazide 12 point 5 mg tab , tab thyroxine 50 mcg , thyroxine sodium 0 point 1mg tab , syp zinc 20 mg_5 ml bottle of 100 ml , folic acid 5 mg tab , omeprazole 20 mg cap , omeprazole 20 mg domperidone 10 mg cap , ascorbic acid 500 mg tab , atorvastatin 20 mg tab , sodium chloride 0 point 65 percent w_v nasal drops of 15 ml , ofloxacin 0 point 3 percent bott of 5 ml , adrenaline tartrate 1_1000 1 ml inj , vit b 12 500 mcg_ml inj , apparatus oxygen inhalation portable facemask disposable for adult , apparatus oxygen inhalation portable facemask disposable for paedtric , sodium chloride solution isotonic in nontoxic disposable plastic bottle of 500ml ffs , sodium lactate compound solution ringer lactate solution in nontoxic disposable plastic bottle of 500ml ffs , isosorbide dinitrate 10 mg tab , tab mefenamic acid 250 mg and tranexamic acid 500 mg , sun screen lotion , enalapril 10 mg , domperidone syp 1 mg_ml bott of 30 ml , diazepam 5 mg tab , tab paracetamol 650 mg , analgesic spray containing diclofenac diethylamine 1 point 16 percent w_w equivalent to 1 percent methyl salicylate 10 percent w_w menthol 5 percent w_w linseed oil , levocetirizine dihcl 2 point 5 mg and montelukast 4 mg , syp disodium hydrogen citrate solution alkasol , an cl
ass="text-red-selected">hep
atitisan> b v
accine 10 ml , inj nitilmicin 300 mg_3 ml , hydroxyprogesterone c
apro
ate 500 mg_2 ml
amp of 2 ml inj , inj metoprolol 1 mg 5 ml
amp , cough expector
ant syrup_ e
ach 5 ml cont
aining diphenhydr
aminehydrochloride 14 mg
ammonium chloride 0 point 135 g sodium citr
ate 57 mg menthol 0 point 9 mg bott of 110 ml , cough sed
ative syp e
ach 5 ml cont
aining chlorphenir
amine m
ale
ate 2 point 5mg gu
aiphenesin 100mg nosc
apine 15mg sodium citr
ate 60mg in fl
avoured b
ase bott of 100 ml , formoterol 6 mcg
and budesonide 400 mcg cfc free mdi 120 metered doses , levo s
albut
amol
aerosol p
ack of 200 metered doses e
ach metered dose supplies 50 mcg of levo s
albut
amol , corn c
ap pkt of 4 , etomid
ate 20 mg _ 10 ml , g
ab
apentin 300 mg c
ap , inj dicyclomine hcl 10 mg , phytomen
adione vit k 1 mg_0 point 5 ml inj , cefixime syp 50 mg_5ml bott of 30 ml , t
ab methyle cob
al
amin er 1500 mcg , glimepiride 1mg t
ab , purified vero cell r
abies v
accine ,
albend
azole 400 mg t
ab , t
ab entec
avir 0 point 5 mg , insulin highly purified hum
an neutr
al 40 iu_ml 10 ml inj , hyoscine bromide inj 20 mg_ml 1ml inj , t
ab metformin sr 0 point 5 gm , prometh
azine hcl 25 mg t
ab , bis
acodyl 5 mg t
ab , t
ab bisoprolol fum
ar
ate 5 mg
and telmis
art
an 40 mg , sit
agliptin 100 mg plusmetformin 1000 mg t
ab , rosuv
ast
atin 20 mg t
ab , cefoper
azone sodium
and sulb
actum sodium 1 point 5 gm inj , t
ab dut
asteride 0 point 5 mg , p
aedi
atric syrup c
alcium plusd3 bott of 100 ml , mid
azol
am n
as
al spr
ay , eye dropes ol
apeptidine ,
allopurinol 100 mg t
ab ursodeoxycholic
acid 150mg t
ab, c
alcium c
arbon
ate 500mg t
ab element
al
and vit d3 200 iu to 250 iu t
ab,
amiod
arone hcl 150 mg 3 ml inj, nor
adren
aline bit
artr
ate 2 mg ml 2 ml inj, tr
anex
amic
acid 500 mg 5ml inj,
adenosine 3 mg ml 2 ml inj,
artesun
ate 60 mg inj,
amoxycillin 1g plus cl
avul
anic
acid 200 mg 1 point2 gm inj, enox
ap
arin 40 mg 0 point4ml inj, p
ar
acet
amol with cysteine hcl monohydr
ate //bid det
ails 2 / 75